Literature DB >> 32204922

COVID-19, a worldwide public health emergency.

M Palacios Cruz1, E Santos2, M A Velázquez Cervantes3, M León Juárez4.   

Abstract

A new coronavirus outbreak emerged on the 31st of December 2019 in Wuhan, China, causing commotion among the medical community and the rest of the world. This new species of coronavirus has been termed 2019-nCoV and has caused a considerable number of cases of infection and deaths in China and, to a growing degree, beyond China, becoming a worldwide public health emergency. 2019-nCoV has high homology to other pathogenic coronaviruses, such as those originating from bat-related zoonosis (SARS-CoV), which caused approximately 646 deaths in China at the start of the decade. The mortality rate for 2019-nCoV is not as high (approximately 2-3%), but its rapid propagation has resulted in the activation of protocols to stop its spread. This pathogen has the potential to become a pandemic. It is therefore vital to follow the personal care recommendations issued by the World Health Organisation.
Copyright © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.

Entities:  

Keywords:  Basic reproduction number; Clinical condition; Coronavirus; Cuadro clínico; Diagnosis; Diagnóstico; Número de reproducción básico; Prevención; Prevention; Transmisión; Transmission

Year:  2020        PMID: 32204922     DOI: 10.1016/j.rce.2020.03.001

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  20 in total

1.  Evaluation of the role and usefulness of clinical pharmacists at the Fangcang Hospital during COVID-19 outbreak.

Authors:  Dongyuan Wang; Yihui Liu; Fang Zeng; Chen Shi; Fang Cheng; Yong Han; Yu Zhang
Journal:  Int J Clin Pract       Date:  2021-05-13       Impact factor: 3.149

2.  SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020.

Authors:  Bastian Fischer; Cornelius Knabbe; Tanja Vollmer
Journal:  Euro Surveill       Date:  2020-07

3.  Epidemiology of COVID-19 in Mexico: from the 27th of February to the 30th of April 2020.

Authors:  V Suárez; M Suarez Quezada; S Oros Ruiz; E Ronquillo De Jesús
Journal:  Rev Clin Esp (Barc)       Date:  2020-05-27

4.  [Epidemiology of COVID-19 in Mexico: from the 27th of February to the 30th of April 2020].

Authors:  V Suárez; M Suarez Quezada; S Oros Ruiz; E Ronquillo De Jesús
Journal:  Rev Clin Esp       Date:  2020-05-27       Impact factor: 1.556

5.  The use of personal protective equipment in the COVID-19 pandemic era.

Authors:  Jacek Smereka; Lukasz Szarpak
Journal:  Am J Emerg Med       Date:  2020-04-15       Impact factor: 2.469

6.  Peripheral immunological features of COVID-19 patients in Taizhou, China: A retrospective study.

Authors:  Xiao-Hong Jin; Hui-Li Zhou; Ling-Ling Chen; Guan-Fu Wang; Qiu-Yue Han; Jian-Gang Zhang; Xia Zhang; Qiong-Yuan Chen; Yao-Han Ye; Aifen Lin; Wei-Hua Yan
Journal:  Clin Immunol       Date:  2020-11-28       Impact factor: 3.969

7.  Gender Differences in Psychological Impact of the Confinement During the COVID-19 Outbreak in Spain: A Longitudinal Study.

Authors:  Javier Fenollar-Cortés; Óliver Jiménez; Antonio Ruiz-García; Davinia M Resurrección
Journal:  Front Psychol       Date:  2021-06-24

8.  Influence of COVID-19 pandemic on hospitalizations at the tertiary dermatology department in south-west Poland.

Authors:  Rafał Białynicki-Birula; Iga Siemasz; Agnieszka Otlewska; Łukasz Matusiak; Jacek C Szepietowski
Journal:  Dermatol Ther       Date:  2020-07-03       Impact factor: 3.858

9.  [Medicine, epidemiology and humanism before and after COVID-19].

Authors:  J B Soriano
Journal:  Rev Clin Esp (Barc)       Date:  2020-05-11

10.  Contributions of Latin American researchers in the understanding of the novel coronavirus outbreak: a literature review.

Authors:  Karen Y Fiesco-Sepúlveda; Luis Miguel Serrano-Bermúdez
Journal:  PeerJ       Date:  2020-06-04       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.